Published in Nat Genet on October 01, 2002
Patterned paper as a platform for inexpensive, low-volume, portable bioassays. Angew Chem Int Ed Engl (2007) 5.58
Simple telemedicine for developing regions: camera phones and paper-based microfluidic devices for real-time, off-site diagnosis. Anal Chem (2008) 4.59
Three-dimensional microfluidic devices fabricated in layered paper and tape. Proc Natl Acad Sci U S A (2008) 4.12
A microchip CD4 counting method for HIV monitoring in resource-poor settings. PLoS Med (2005) 2.90
FLASH: a rapid method for prototyping paper-based microfluidic devices. Lab Chip (2008) 2.78
Microfluidics-based diagnostics of infectious diseases in the developing world. Nat Med (2011) 2.68
Setting global health research priorities. BMJ (2003) 2.43
Using personal glucose meters and functional DNA sensors to quantify a variety of analytical targets. Nat Chem (2011) 1.93
Health and economic benefits of an accelerated program of research to combat global infectious diseases. CMAJ (2004) 1.93
A research agenda for gastrointestinal and endoscopic surgery. Surg Endosc (2007) 1.72
Nanotechnology and the developing world. PLoS Med (2005) 1.66
Comparison of PCR with the routine procedure for diagnosis of tuberculosis in a population with high prevalences of tuberculosis and human immunodeficiency virus. J Clin Microbiol (2004) 1.53
Emergence of Diseases of Affluence in Oman: Where do they Feature in the Health Research Agenda? Sultan Qaboos Univ Med J (2006) 1.38
Using polymeric materials to generate an amplified response to molecular recognition events. Nat Mater (2007) 1.33
Low-cost printing of poly(dimethylsiloxane) barriers to define microchannels in paper. Anal Chem (2008) 1.30
Neglected diseases: under-funded research and inadequate health interventions. Can we change this reality? EMBO Rep (2003) 1.29
Miniaturized lensless imaging systems for cell and microorganism visualization in point-of-care testing. Biotechnol J (2011) 1.25
Advances in plasmonic technologies for point of care applications. Chem Rev (2014) 1.16
Phytoremediation of polychlorinated biphenyls: new trends and promises. Environ Sci Technol (2010) 1.13
Health research systems: promoting health equity or economic competitiveness? Bull World Health Organ (2011) 1.09
The association of beliefs about heredity with preventive and interpersonal behaviors in communities affected by podoconiosis in rural Ethiopia. Am J Trop Med Hyg (2012) 1.08
How can developing countries harness biotechnology to improve health? BMC Public Health (2007) 1.06
"Harnessing genomics to improve health in India" - an executive course to support genomics policy. Health Res Policy Syst (2004) 1.06
Formation and characterization of an ideal excitation beam geometry in an optofluidic device. Biomed Opt Express (2010) 1.05
Proteasome-independent major histocompatibility complex class I cross-presentation mediated by papaya mosaic virus-like particles leads to expansion of specific human T cells. J Virol (2006) 1.04
Using commercially available personal glucose meters for portable quantification of DNA. Anal Chem (2012) 1.03
Public engagement on global health challenges. BMC Public Health (2008) 1.01
RiceFOX: a database of Arabidopsis mutant lines overexpressing rice full-length cDNA that contains a wide range of trait information to facilitate analysis of gene function. Plant Cell Physiol (2010) 0.99
Portable and quantitative detection of protein biomarkers and small molecular toxins using antibodies and ubiquitous personal glucose meters. Anal Chem (2012) 0.95
A low-cost ultrasound program leads to increased antenatal clinic visits and attended deliveries at a health care clinic in rural Uganda. PLoS One (2013) 0.95
Low cost extraction and isothermal amplification of DNA for infectious diarrhea diagnosis. PLoS One (2013) 0.93
"Harnessing genomics to improve health in Africa" - an executive course to support genomics policy. Health Res Policy Syst (2005) 0.92
Strengthening the role of genomics in global health. PLoS Med (2004) 0.91
Harnessing genomics to improve health in the Eastern Mediterranean Region - an executive course in genomics policy. Health Res Policy Syst (2005) 0.90
Technology in global health: the need for essential diagnostics. Lancet (2008) 0.87
Research priorities in surgical simulation for the 21st century. Am J Surg (2012) 0.87
SAGES research agenda in gastrointestinal and endoscopic surgery: updated results of a Delphi study. Surg Endosc (2014) 0.86
Regenerative medicine and the developing world. PLoS Med (2006) 0.86
Cotton-based diagnostic devices. Sci Rep (2014) 0.84
Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept. OMICS (2011) 0.83
A call for global governance of biobanks. Bull World Health Organ (2014) 0.80
Germs, genomics and global public health: How can advances in genomic sciences be integrated into public health in the developing world to deal with infectious diseases? Hugo J (2009) 0.79
Printed Flexible Plastic Microchip for Viral Load Measurement through Quantitative Detection of Viruses in Plasma and Saliva. Sci Rep (2015) 0.79
Pharmacogenomic technologies: a necessary "luxury" for better global public health? Global Health (2011) 0.78
Developing biobanks in developing countries. J Glob Health (2011) 0.78
Coupling Sensitive Nucleic Acid Amplification with Commercial Pregnancy Test Strips. Angew Chem Int Ed Engl (2016) 0.77
Low-Cost 3D Printers Enable High-Quality and Automated Sample Preparation and Molecular Detection. PLoS One (2016) 0.77
Pharmacologically triggered hydrogel for scheduling hepatitis B vaccine administration. Sci Rep (2013) 0.77
Colposcopically observed vascular changes in the cervix in relation to the hormonal levels and menstrual cycle. J Low Genit Tract Dis (2008) 0.75
Fabrication of a gel particle array in a microfluidic device for bioassays of protein and glucose in human urine samples. Biomicrofluidics (2011) 0.75
Bioactive paper sensor based on the acetylcholinesterase for the rapid detection of organophosphate and carbamate pesticides. Int J Anal Chem (2014) 0.75
Past speculations of the future: a review of the methods used for forecasting emerging health technologies. BMJ Open (2016) 0.75
Factors Affecting Women's Autonomous Decision Making In Research Participation Amongst Yoruba Women Of Western Nigeria. Dev World Bioeth (2016) 0.75
Connecting the Human Variome Project to nutrigenomics. Genes Nutr (2010) 0.75
Paper-based CRP Monitoring Devices. Sci Rep (2016) 0.75
The Development of Computational Biology in South Africa: Successes Achieved and Lessons Learnt. PLoS Comput Biol (2016) 0.75
A low cost design and fabrication method for developing a leak proof paper based microfluidic device with customized test zone. Biomicrofluidics (2015) 0.75
Genomics for all. Nat Genet (2002) 0.75
Equal partnership to ensure that developing countries benefit from genomics. Nat Genet (2003) 0.75
Understanding biological mechanisms underlying adverse birth outcomes in developing countries: protocol for a prospective cohort (AMANHI bio-banking) study. J Glob Health (2017) 0.75
Grand challenges in global mental health. Nature (2011) 8.40
Grand challenges in chronic non-communicable diseases. Nature (2007) 7.86
Grand challenges in global health: community engagement in research in developing countries. PLoS Med (2007) 4.75
Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract (2012) 4.11
CPR for patients labeled DNR: the role of the limited aggressive therapy order. Ann Intern Med (2003) 3.54
Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid (2012) 2.85
Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. J Clin Endocrinol Metab (2005) 2.79
Brazilian health biotech--fostering crosstalk between public and private sectors. Nat Biotechnol (2008) 2.57
India's health biotech sector at a crossroads. Nat Biotechnol (2007) 2.53
Quality care at the end of life. BMJ (2002) 2.40
Public engagement in setting priorities in health care. CMAJ (2008) 2.37
Setting priorities in health care organizations: criteria, processes, and parameters of success. BMC Health Serv Res (2004) 2.06
Priority setting in a hospital critical care unit: qualitative case study. Crit Care Med (2003) 2.01
Chinese health biotech and the billion-patient market. Nat Biotechnol (2008) 2.00
Priority setting: what constitutes success? A conceptual framework for successful priority setting. BMC Health Serv Res (2009) 1.82
Global health. Stagnant health technologies in Africa. Science (2010) 1.68
Grand challenges in global health: engaging civil society organizations in biomedical research in developing countries. PLoS Med (2007) 1.68
Nanotechnology and the developing world. PLoS Med (2005) 1.66
Small but tenacious: South Africa's health biotech sector. Nat Biotechnol (2009) 1.63
Priority setting in hospitals: fairness, inclusiveness, and the problem of institutional power differences. Soc Sci Med (2005) 1.62
Accountable priority setting for trust in health systems--the need for research into a new approach for strengthening sustainable health action in developing countries. Health Res Policy Syst (2009) 1.61
Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society. Endocr Pract (2005) 1.60
Fairness, accountability for reasonableness, and the views of priority setting decision-makers. Health Policy (2002) 1.55
A strategy to improve priority setting in developing countries. Health Care Anal (2007) 1.53
Grand challenges in global health: ethical, social, and cultural issues based on key informant perspectives. PLoS Med (2007) 1.50
Intensive care nurses' and physicians' experiences with demands for treatment: some implications for clinical practice. J Crit Care (2003) 1.48
Global health challenges: the need for an expanded discourse on bioethics. PLoS Med (2005) 1.46
The three main monotheistic religions and gm food technology: an overview of perspectives. BMC Int Health Hum Rights (2009) 1.45
Innovative health service delivery models in low and middle income countries - what can we learn from the private sector? Health Res Policy Syst (2010) 1.44
Patients' views about cardiac report cards: a qualitative study. Can J Cardiol (2005) 1.44
Ethical issues related to cardiac report cards. Can J Cardiol (2004) 1.42
Fairness and accountability for reasonableness. Do the views of priority setting decision makers differ across health systems and levels of decision making? Soc Sci Med (2008) 1.40
Responsibilities in international research: a new look revisited. J Med Ethics (2010) 1.39
Conclusions: promoting biotechnology innovation in developing countries. Nat Biotechnol (2004) 1.38
Priority setting at the micro-, meso- and macro-levels in Canada, Norway and Uganda. Health Policy (2006) 1.35
South Africa--blazing a trail for African biotechnology. Nat Biotechnol (2004) 1.34
SARS and hospital priority setting: a qualitative case study and evaluation. BMC Health Serv Res (2004) 1.33
Priority setting in developing countries health care institutions: the case of a Ugandan hospital. BMC Health Serv Res (2006) 1.32
Participation in health care priority-setting through the eyes of the participants. J Health Serv Res Policy (2002) 1.30
Science community: scientific diasporas. Science (2006) 1.29
What do district health planners in Tanzania think about improving priority setting using 'Accountability for reasonableness'? BMC Health Serv Res (2007) 1.28
Priority setting and cardiac surgery: a qualitative case study. Health Policy (2006) 1.28
Evaluating priority setting success in healthcare: a pilot study. BMC Health Serv Res (2010) 1.27
Pharmacogenetics and geographical ancestry: implications for drug development and global health. Nat Rev Genet (2005) 1.24
The effect of priority setting decisions for new cancer drugs on medical oncologists' practice in Ontario: a qualitative study. BMC Health Serv Res (2007) 1.23
Responding to trust: surgeons' perspective on informed consent. World J Surg (2009) 1.20
Harnessing stem cells for health needs in India. Cell Stem Cell (2008) 1.19
'Relief of oppression': an organizing principle for researchers' obligations to participants in observational studies in the developing world. BMC Public Health (2010) 1.19
A business plan to help the 'global South' in its fight against neglected diseases. Health Aff (Millwood) (2009) 1.19
Biotechnology and the UN's Millennium Development Goals. Nat Biotechnol (2003) 1.19
Successful priority setting in low and middle income countries: a framework for evaluation. Health Care Anal (2009) 1.18
Hospital priority setting with an appeals process: a qualitative case study and evaluation. Health Policy (2004) 1.18
Evidence, economics and ethics: resource allocation in health services organizations. Healthc Q (2005) 1.17
Top 10 health care ethics challenges facing the public: views of Toronto bioethicists. BMC Med Ethics (2005) 1.13
Regenerative medicine in Brazil: small but innovative. Regen Med (2010) 1.12
Genomics--a global public good? Lancet (2003) 1.11
Shared principles of ethics for infant and young child nutrition in the developing world. BMC Public Health (2010) 1.11
The Indian and Chinese health biotechnology industries: potential champions of global health? Health Aff (Millwood) (2008) 1.11
Leadership and priority setting: the perspective of hospital CEOs. Health Policy (2005) 1.10
Introduction: promoting global health through biotechnology. Nat Biotechnol (2004) 1.10
A visual dashboard for moving health technologies from "lab to village". J Med Internet Res (2007) 1.10
Priority setting for new technologies in medicine: a transdisciplinary study. BMC Health Serv Res (2002) 1.08
How can developing countries harness biotechnology to improve health? BMC Public Health (2007) 1.06
Cuba--innovation through synergy. Nat Biotechnol (2004) 1.06
"Harnessing genomics to improve health in India" - an executive course to support genomics policy. Health Res Policy Syst (2004) 1.06
Consensus guidelines on analgesia and sedation in dying intensive care unit patients. BMC Med Ethics (2002) 1.06
Recognition and management of delayed hyponatremia following transsphenoidal pituitary surgery. J Neurosurg (2007) 1.05
Priority setting for orphan drugs: an international comparison. Health Policy (2010) 1.04
Priority setting in surgery: improve the process and share the learning. World J Surg (2003) 1.04
Genomics knowledge and equity: a global public goods perspective of the patent system. Bull World Health Organ (2004) 1.03
Intimate examinations and other ethical challenges in medical education. BMJ (2003) 1.03
Lessons on ethical decision making from the bioscience industry. PLoS Med (2006) 1.03
Case study: India's billion dollar biotech. Nat Biotechnol (2010) 1.02
What do hospital decision-makers in Ontario, Canada, have to say about the fairness of priority setting in their institutions? BMC Health Serv Res (2005) 1.01
Public engagement on global health challenges. BMC Public Health (2008) 1.01
Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nat Rev Genet (2008) 1.01
A qualitative study of attitudes toward error in patients facing brain tumour surgery. Can J Neurol Sci (2004) 1.01
Interdisciplinary research: putting the methods under the microscope. BMC Med Res Methodol (2003) 0.99
Genomic medicine and developing countries: creating a room of their own. Nat Rev Genet (2008) 0.99
"The best places to die". BMJ (2003) 0.99
South-South entrepreneurial collaboration in health biotech. Nat Biotechnol (2010) 0.99